Market news
Stocks and crypto headlines from Alpaca. Stored for 7 days. Total: 9743.
-
Analysts Adjust Price Targets for Revvity Following Q3 EarningsMultiple financial institutions, including Stifel Nicolaus, Goldman Sachs, and JPMorgan, updated their price targets for Revvity on November 4, 2026, following the company's third-quarter earnings report.
-
Keefe Bruyette & Woods Downgrades Cipher Digital to Market PerformKeefe Bruyette & Woods downgraded Cipher Digital to Market Perform with a price target of $9.50.
-
MoffettNathanson Raises Price Target on Cinemark Holdings to $46MoffettNathanson has increased its price target for Cinemark Holdings, Inc. from $41 to $46 while maintaining a Buy rating.
-
Wedbush Raises Price Target on Cinemark Holdings to $46Wedbush has increased its price target for Cinemark Holdings, Inc. from $45 to $46 while maintaining an Outperform rating.
-
Morgan Stanley Raises Price Target on Broadridge Financial SolutionsMorgan Stanley increased its price target for Broadridge Financial Solutions from $176 to $181.
-
Tango Therapeutics and Erasca Announce Phase 1/2 Study Update for PRMT5 InhibitorTango Therapeutics and Erasca have provided an update regarding their ongoing Phase 1/2 clinical study of an oral PRMT5 inhibitor.
-
Wedbush Adjusts D-Wave Quantum Price Target to $30Wedbush Securities lowered its price target for D-Wave Quantum Inc. from $37 to $30 while maintaining an Outperform rating.
-
MGE Energy, Inc. Reports Third Quarter 2026 Financial ResultsMGE Energy, Inc. announced an increase in third-quarter earnings and revenue compared to the same period in the previous year.
-
Legend Biotech Announces Multiple Abstracts Accepted for 2026 ASH Annual MeetingLegend Biotech will present new clinical and real-world data for CARVYKTI and updates on its next-generation cell therapy programs at the 2026 American Society of Hematology (ASH) Annual Meeting.
-
Disc Medicine Announces Multiple Presentations at the 68th ASH Annual MeetingDisc Medicine will present additional data from its Phase 2 clinical trials for selcodebart (DISC-0974) and DISC-3405 at the upcoming 68th American Society of Hematology (ASH) Annual Meeting.
-
Reynolds Consumer Products Reports Q3 2026 Financial ResultsReynolds Consumer Products announced its third-quarter 2026 financial results, reporting revenue of $944 million and adjusted earnings per share of $0.39.
-
Atlanta Braves Holdings Reports Third Quarter 2026 Financial ResultsAtlanta Braves Holdings, Inc. reported its financial results for the third quarter ended September 30, 2026, noting revenue of $324.6 million and earnings per share of $0.15.
-
AllianceBernstein Launches Actively Managed AB Equity Premium Income ETFAllianceBernstein has introduced the AB Equity Premium Income ETF, an actively managed fund designed to provide income and equity market exposure through a covered-call strategy.
-
Amylyx Pharmaceuticals to Host Investor Event at ObesityWeek® 2026Amylyx Pharmaceuticals announced it will host an investor event at the upcoming ObesityWeek® 2026 conference, featuring experts in post-bariatric hypoglycemia (PBH).
-
Riot Platforms Reports Q3 2026 Financial ResultsRiot Platforms reported third-quarter 2026 revenue of $181.4 million, exceeding analyst estimates of $160.8 million.
-
ABM Industries to Participate in RW Baird Global Industrial ConferenceABM Industries announced that its CFO and SVP of Investor Relations will participate in a fireside chat at the upcoming RW Baird Global Industrial Conference.
-
Bread Financial to Participate in the KBW Fintech Ecosystem ConferenceBread Financial announced that its Chief Financial Officer, Perry Beberman, will participate in a fireside chat at the KBW Fintech Ecosystem Conference.
-
AvePoint Appoints Ali Rohani as Chief Strategy and Customer OfficerAvePoint has appointed Ali Rohani to the newly created role of Chief Strategy and Customer Officer to enhance customer value and accelerate company growth.
-
Global Renewable Energy Stocks Rise Following US Midterm Election ResultsShares of Enphase Energy and other major renewable energy companies saw significant gains in premarket trading following reports that the Democratic Party secured control of the US Congress.
-
Insulet Reports Third Quarter 2026 Financial Results and Announces $1 Billion Share Repurchase ProgramInsulet Corporation reported strong third-quarter 2026 financial results, exceeding analyst expectations, and authorized a new $1 billion share repurchase program.